FIELD: pharmaceutics. SUBSTANCE: invention relates to substances of submicrometer size or other water-insoluble or difficultly water-soluble substances that are produced by using a combination of one or more surface-active substance as a surface modifying agent, for example, polaxomers, poloxamines, polyoxyethylene sorbitol and saturated acid esters and similar with natural or synthetic phospholipids. Obtained particles show average-weighted by volume size but two-fold smaller as compared with particles obtained with phospholipid using only. Prepared composites are stable with respect to increase of particles size at storage. EFFECT: enhanced stability of composites at storage. 16 cl, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
MANUFACTURE OF MEDICINAL PREPARATIONS BY USING PROPOFOL MICRODROPS | 1997 |
|
RU2186564C2 |
DISPERSABLE MICROPARTICLES STABILIZED WITH PHOSPHOLIPID | 1999 |
|
RU2233654C2 |
AQUEOUS SUSPENSION CONTAINING MICROCRYSTALS OF PHARMACOLOGICALLY ACTIVE WATER-INSOLUBLE MEDICINAL SUBSTANCE AND COVERED WITH MEMBRANE-FORMING LIPID (VARIANTS) AND LYOPHILIZED PREPARATION OF AN AQUEOUS SUSPENSION | 1992 |
|
RU2100030C1 |
BASED ON BOTANICAL PHOSPHOLIPIDS NANOSYSTEM FOR ACTUATION OF BIOLOGICALLY ACTIVE COMPOUNDS, AND METHOD OF ITS MANUFACTURE (VERSIONS) | 2009 |
|
RU2391966C1 |
PHARMACEUTIC COMPOSITION INCLUDING ARBIDOL IN COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | 2009 |
|
RU2411942C2 |
LIPOSOMAL AGENT BASED ON UBIQUINOL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2605616C1 |
COMPOSITION OF DIHYDROQUERCETINE ENCLOSED IN PHOSPHOLIPID NANOPARTICLES | 2013 |
|
RU2536208C1 |
INHALATION FATTY EMULSION | 1999 |
|
RU2212230C2 |
DEPOT FORMULATIONS OF HYDROPHOBIC ACTIVE INGREDIENT AND METHODS FOR PREPARATION THEREOF | 2013 |
|
RU2678433C2 |
IMPROVED PREPARATION FOR TOPICAL NON-INVASIVE USING IN VIVO | 1998 |
|
RU2207844C2 |
Authors
Dates
2002-08-10—Published
1997-03-28—Filed